• Up 1,511% in a year, guess which ASX uranium share is storming higher again on Wednesday

    Rocket going up above mountains, symbolising a record high.

    ASX uranium share Cauldron Energy Ltd (ASX: CXU) is at it again.

    And by ‘it’, I mean rocketing higher.

    Cauldron Energy shares closed yesterday trading for 13 cents. In late morning trade on Wednesday, shares are changing hands for 14.5 cents apiece, up 11.5%.

    For some context, the S&P/ASX Small Ordinaries Index (ASX: XSO) is up 0.6% at this same time.

    With today’s intraday gains factored in, the junior ASX uranium share cements its place as a 10-bagger-plus. (That’s a stock that returns at least 10-times your original investment within a relatively modest time frame.)

    Indeed, 12 months ago, you could have picked up Cauldron Energy shares for just 0.9 cents each. Meaning the stock has gained a jaw-dropping 1,511.1%.

    Or enough to turn a $10,000 investment into $161,111.

    In one year!

    The miner has been benefiting from a series of exploration successes and strategic acquisitions, along with rising uranium prices.

    Now, here’s what’s stoking ASX investor interest again today.

    ASX uranium share jumps on drill results

    The Cauldron Energy share price is rocketing following an update on the company’s Yanrey Uranium Project, located in Western Australia.

    The ASX uranium share revealed that the results it just received for the first 14 drill holes of its 2026 drill campaign have returned high-grade uranium results at the Manyingee North Deposit, within Yanrey.

    Manyingee North was earlier reported to host an existing Inferred Mineral Resource Estimate of 14.9 million tonnes containing 9.8 million pounds of uranium at an average grade of 297 ppm eU3O8 (equivalent uranium oxide).

    Cauldron CEO Jonathan Fisher noted that the start of the company’s drill campaign was “slightly delayed due to weather and a little slow to ramp up due to some minor technical issues (now resolved), which led us being a little later than we initially expected in getting these first results out”.

    Top results from one of the drill holes included:

    • 30 metres at 258.3 ppm eU3O8 from 91.62 metres
    • 70 metres at 243.0 ppm eU3O8 from 94.42 metres

    What did Cauldron Energy management say?

    Commenting on the successful 2026 drill program launch that’s boosting the ASX uranium share today, Fisher said:

    The program is now humming and from a results perspective, it’s been a great start to the 2026 drill program with all holes drilled at Manyingee North returning mineralisation, extended the mineralisation north and south to around 4 kilometres of strike, with mineralisation remaining open in all directions.

    Looking ahead, Fished added:

    With the extraordinary global macro thematic and all the positive news recently around the Australia India uranium arrangements and what that might possibly mean for the need to lift state restrictions and build new mines to satisfy demand, it’s a great time to be out drilling and demonstrating the prolific nature and scale of the uranium project at Yanrey.

    We will keep the rig spinning and look forward to reporting the next set of results!

    The post Up 1,511% in a year, guess which ASX uranium share is storming higher again on Wednesday appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Cauldron Energy right now?

    Before you buy Cauldron Energy shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cauldron Energy wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Up over 1,000%: Can the best-performing stocks on the ASX 200 keep rising?

    Woman looks amazed and shocked as she looks at her laptop.

    The S&P/ASX 200 Index (ASX: XJO) has had a choppy time over the past 12 months as global volatility, share market uncertainty, interest rate stress, and fickle investors saw shares across the index swing wildly.

    At the time of writing, the ASX 200 Index is just over 0.5% higher year to date and around 1% higher than 12 months ago.

    Around half of the shares on the index are now trading lower than they were 12 months ago. But, on the flip side, there are some standout performers that have roared higher over the past year.

    4DMedical Ltd (ASX: 4DX) and Sunrise Energy Metals Ltd (ASX: SRL) shares have each risen by more than 1,000% over the past 12 months. 

    Find out if they can keep climbing higher.

    Are 4DMedical shares a buy, sell, or hold?

    4DMedical shares have risen 1,215% over the past 12 months and are trading at $3.42 a piece at the time of writing. The ASX healthcare business is the strongest performer on the ASX 200 Index over the past 12 months.

    The company saw its share price explode in 2025 after its flagship product, CT:VQ, received regulatory approvals. It was quickly implemented and adopted through various contracts and partnerships with major hospitals and medical providers, primarily across the US. 

    The leap in development and fast adoption means 4DMedical moved very quickly from a research and development business to a globally commercial business.

    The share price peaked at an all-time high of $6.80 a piece in April this year. This was when the company joined the ASX 200 Index. 

    But the shares quickly shed around 50% after a broad sell-off of ASX 200 healthcare stocks drove many shares across the sector to low levels. It’s also likely that many investors rushed to take their gains off the table after an incredible run-up.

    Since then, the shares have been relatively flat as investors try to work out whether the business has the potential to keep growing.

    4D Medical is still in its growth phase and is working to expand its commercial footprint further. Approvals have been secured in Canada and New Zealand. The company is now actively progressing commercialisation plans in Europe and Australia.

    It looks like analysts are divided about the outlook for the shares.

    TradingView data shows three analysts are split between strong buy, hold, and strong sell ratings. A $4.97 target price implies a 45% upside at the time of writing. But some think the shares have the potential to jump 75% to $6 a piece over the next 12 months.

    Are Sunrise Energy shares a buy, sell, or hold?

    Sunrise Energy is not officially a member of the ASX 200. But the company currently ranks in 194th place across all ASX-listed companies (out of 2,336) based on its market capitalisation of $2.4 billion.

    Sunrise Energy develops huge mining and mineral processing projects. Essentially, the company develops and manages the application of ion-exchange technology. This technology is used to extract valuable metals for the mining industry and to purify and recycle wastewater.

    The Australian minerals company is also developing one of the world’s largest and highest-grade primary scandium and nickel-cobalt deposits. Its flagship operation is the Syerston Project in central-west NSW.

    This exposure gives Sunrise Energy a unique position in an emerging market where demand is booming, but there aren’t many credible suppliers. 

    Over the past 12 months, Sunrise Energy shares have climbed by over 1,050%. The shares are trading at $15.42 a piece at the time of writing. The increase has been relatively consistent over that period, too.

    The share price spiked at $18.59 in late June and has cooled slightly since then, most likely due to investors taking gains off the table after the huge rally. 

    The challenge for investors is that analyst coverage on the stock is limited. TradingView data shows that only one broker currently covers Sunrise Energy. However, that broker has a strong buy rating and a $20 target price on the shares. At the time of writing, that implies a potential 30% upside over the next 12 months.

    The post Up over 1,000%: Can the best-performing stocks on the ASX 200 keep rising? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in 4DMedical right now?

    Before you buy 4DMedical shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4DMedical wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why are Lynas shares getting hammered on Wednesday?

    Hammer next to broken piggy bank.

    Lynas Rare Earths Ltd (ASX: LYC) shares are taking a beating today.

    Shares in the S&P/ASX 200 Index (ASX: XJO) rare earths miner closed yesterday trading for $15.96. In morning trade on Wednesday, shares are changing hands for $15.04 apiece, down 5.8%.

    For some context, the ASX 200 is up 0.1% at this same time.

    This follows the release of Lynas’ fourth-quarter update (Q4 FY 2024).

    Investor expectations appear to be high after the strong run higher in Lynas shares over the past year. Despite today’s pullback, the share price remains up 48.6% in 12 months.

    Here’s what’s happening.

    Lynas shares tumble despite surging revenue

    The ASX 200 rare earths stock is under selling pressure despite reporting some solid results.

    For the three months to 30 June, Lynas recorded gross sales revenue of $288.9 million, up 69.7% year on year. That marks the miner’s highest quarterly revenue since Q4 FY 2022.

    Sales receipts of $297.1 million were up 94.6%.

    Revenue was boosted by a material increase in the average selling price across all the company’s rare earth products, which hit a record $98.2 per kilogram over the quarter. Management credited improved NdPr (Neodymium-Praseodymium) pricing, an increased mix of heavy rare earth sales, and increased premiums over the market index.

    The quarter saw Lynas produce 3,481 tonnes of total rare earth oxide (REO), up 8% from the prior corresponding quarter. But Lynas shares could be facing some pressure with NdPr production of 1,857 tonnes, down 11% year on year.

    Over the quarter, Lynas’ CAPEX, exploration, and development costs totalled $27.8 million.

    Turning to the balance sheet, as at 30 June, Lynas held $1.21 billion in cash and short-term deposits, up more than 600% year on year.

    What did management say?

    Commenting on the results that have yet to lift the Lynas share price today, interim CEO Pol Le Roux said:

    The June quarter 2026 saw the continued focus on the efficient operation of our A$1.5 billion investment in new capacity which was completed as part of the Lynas 2025 growth initiative. This includes the ramp up of the expanded Mt Weld processing plant and addressing bottlenecks at the Kalgoorlie Rare Earths Processing Facility.

    Le Roux also pointed to the growth potential on offer from Lynas’ Samarium oxide operations.

    He noted:

    Following production of the first Samarium oxide in March 2026, we have received strong customer demand and the customer qualification process is underway. Samarium is used in high performance magnets for electronics and aerospace as well as optical, catalyst and medical applications. The first customer orders are expected to be fulfilled in the current quarter (Q1 FY27).

    The post Why are Lynas shares getting hammered on Wednesday? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Lynas Rare Earths Ltd right now?

    Before you buy Lynas Rare Earths Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Lynas Rare Earths Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.